Clinical Trial Update: L-Citrulline Dose Finding Safety Study in MELAS [Phase 1]

View source ↗

Summary

Phase 1 safety and dose-finding study of L-Citrulline in MELAS syndrome has completed, assessing tolerability and safe dose ranges.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melas Syndrome

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Baylor College of Medicine | Conditions: MELAS Syndrome | Phase 1 | Status: COMPLETED